SCHEMBL705825

SCHEMBL705825

COc1cc(OC)cc(C(=O)c2cc3cc(OCc4ccccc4)ccc3n2CCc2ccccc2)c1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.57
LTB4R Q15722 1/20 0.54
LTB4R2 Q9NPC1 1/20 0.54
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
POLB P06746 2/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
F10 P00742 2/20 0.47
SRD5A1 P18405 1/20 0.44
FLT3 P36888 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL709317 0.91 MCL1 (0.47) SRD5A2LTB4RLTB4R2MEN1KMT2A
SCHEMBL709318 0.87 PLA2G4A (0.45) SRD5A2LTB4RLTB4R2MEN1KMT2A
SCHEMBL13802519 0.84 SRD5A2 (0.72) SRD5A2LTB4RLTB4R2MEN1KMT2A
SCHEMBL706447 0.82 LPAR1 (0.52) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL709549 0.80 HDAC1 (0.58) SRD5A2LTB4RLTB4R2MEN1KMT2A
SCHEMBL706891 0.80 KMT2A (0.42) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL708944 0.77 LPAR1 (0.52) MEN1KMT2APOLBKDM4E
SCHEMBL13802531 0.76 SRD5A2 (0.74) SRD5A2LTB4RLTB4R2MEN1KMT2A
SCHEMBL707824 0.76 LPAR1 (0.52)
SCHEMBL3967516 0.74 CCR2 (0.73) SRD5A2LTB4RLTB4R2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1553075-B1 LPA RECEPTOR ANTAGONISTS ONO PHARMACEUTICAL CO (JP) 2013-08-14 EP disclosed
EP-2565178-A1 LPA Receptor Antagonists ONO PHARMACEUTICAL CO., LTD. (JP) 2013-03-06 EP disclosed
US-20120088782-A1 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-12 US disclosed
US-8124645-B2 LPA receptor antagonist ONO PHARMACEUTICAL CO., LTD. (JP) 2012-02-28 US disclosed
US-7820682-B2 LPA receptor antagonist ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-26 US disclosed
US-20100249157-A2 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-30 US disclosed
US-20080293764-A1 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. 2008-11-27 US disclosed
US-20060148830-A1 Lpa receptor antagonist ONO PHARMACEUTICAL CO., LTD. 2006-07-06 US disclosed
EP-1553075-A1 LPA RECEPTOR ANTAGONISTS ONO PHARMACEUTICAL CO., LTD. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293764-A1 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 SRD5A2 3345/4885LTB4R 67/4885LTB4R2 59/4885
US-20100249157-A2 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 SRD5A2 3345/4885LTB4R 67/4885LTB4R2 59/4885
US-20120088782-A1 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 SRD5A2 3345/4885LTB4R 67/4885LTB4R2 59/4885
US-20060148830-A1 Lpa receptor antagonist LPAR1, LPAR2, LPAR4 SRD5A2 3345/4885LTB4R 67/4885LTB4R2 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.